Treatment of rheumatic diseases.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000962:Antimalarials / Q000009:adverse effects; D001942:Breast Feeding; D064420:Drug-Related Side Effects and Adverse Reactions; D005314:Embryonic and Fetal Development / Q000187:drug effects; D005260:Female; D006046:Gold / Q000009:adverse effects; D006801:Humans; D010396:Penicillamine / Q000009:adverse effects; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D012216:Rheumatic Diseases / Q000188:drug therapy*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000962:Antimalarials; D006046:Gold; D010396:Penicillamine